Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 804-815

  Yip, Linda ^a   Kwok, Yin Nam ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY 1 [6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] N METHYL BETA DEXTRO RIBOFURANURONAMIDE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; CYCLOHEXYLADENOSINE; GASTRIN; MESSENGER RNA; PHENYLISOPROPYLADENOSINE; SOMATOSTATIN; UNCLASSIFIED DRUG; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; GASTRIN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSTATIN CELL; SOMATOSTATIN RELEASE; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; STOMACH PROTECTION; STOMACH SECRETION; STOMACH ULCER; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; STOMACH; TISSUE DISTRIBUTION; WISTAR RAT;

ADENOSINE; ANIMALS; MALE; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; SOMATOSTATIN; STOMACH; TISSUE DISTRIBUTION; TRIAZINES; TRIAZOLES; XANTHINES;

EID: 2142761527     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.061986     Document Type: Article

References (39)

1. Barajas-Lopez C, Surprenant A, and North RA (1991) Adenosine A1 and A2 receptors mediate presynaptic inhibition and postsynaptic excitation in guinea pig submucosal neurons. J Pharmacol Exp Ther 258:490-495.
2. Brackett LE and Daly JW (1994) Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814.
3. Christofi FL, Zhang H, Yu JG, Guzman J, Xue J, Kim M, Wang YZ, and Cooke HJ (2001) Differential gene expression of adenosine A1, A2a, A2b and A3 receptors in the human enteric nervous system. J Comp Neurol 439:46-64.
4. Diniz C, Leal S, and Goncalves J (2003) Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens. Eur J Pharmacol 460:191-199.
5. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, and Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461-1468.
6. Ekblad E, Ekelund M, Graffner H, Hakanson R, and Sundler F (1985) Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology 89:73-85.
7. Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, and Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14:186-195.
8. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, and Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
9. Gallo-Rodriguez C, Ji XD, Melman N, Siegman BD, Sanders LH, Orlina J, Fischer B, Pu Q, Olah ME, van Galen PJ, et al. (1994) Structure-activity relationships of N6-benzyladenosine-5′-uronamides as A3-selective adenosine agonists. J Med Chem 37:636-646.
10. Geiger JD and Glavin GB (1985) Adenosine receptor activation in brain reduces stress-induced ulcer formation. Eur J Pharmacol 115:185-190.
11. Gerber JG, Nies AS, and Payne NA (1985) Adenosine receptors on canine parietal cells modulate gastric acid secretion to histamine. J Pharmacol Exp Ther 233:623-627.
12. Gerber JG and Payne NA (1988) Endogenous adenosine modulates gastric acid secretion to histamine in canine parietal cells. J Pharmacol Exp Ther 244:190-194.
13. Glavin GB, Westerberg VS, and Geiger JD (1987) Modulation of gastric acid secretion by adenosine in conscious rats. Can J Physiol Pharmacol 65:1182-1185.
14. Heldsinger AA, Vinik AI, and Fox IH (1986) Inhibition of guinea-pig oxyntic cell function by adenosine and prostaglandins. J Pharmacol Exp Ther 237:351-356.
15. Hersey SJ and Sachs G (1995) Gastric acid secretion. Physiol Rev 75:155-189.
16. Hutchison AJ, Webb RL, Oei HH, Ghai GR, Zimmerman MB, and Williams M (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47-55.
17. Keast JR, Furness JB, and Costa M (1985) Distribution of certain peptide-containing nerve fibres and endocrine cells in the gastrointestinal mucosa in five mammalian species. J Comp Neurol 236:403-422.
18. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, and Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 357:1-9.
19. Koop H, Behrens I, Bothe E, Koschwitz H, McIntosh CH, Pederson RA, Arnold R, and Creutzfeldt W (1983) Adrenergic control of rat gastric somatostatin and gastrin release. Scand J Gastroenterol 18:65-71.
20. Kwok YN, McIntosh C, and Brown J (1990) Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs. J Pharmacol Exp Ther 255:781-788.
21. Kwok YN, McIntosh CH, Sy H, and Brown JC (1988) Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach. J Pharmacol Exp Ther 246:726-731.
22. Lohse MJ, Klotz KN, Lindenborn-Fotinos J, Reddington M, Schwabe U, and Olsson RA (1987) 8-Cyclopentyl-1,3,dipropylxanthine (DPCPX)-a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 336:204-210.
23. Mendelson WB, Kuruvilla A, Watlington T, Goehl K, Paul SM, and Skolnick P (1983) Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase. Psychopharmacology 79:126-129.
24. Namiot Z, Rutkiewicz J, Stasiewicz J, Baranczuk E, and Marcinkiewicz M (1991) Adenosine deaminase activity in the gastric mucosa in patients with gastric ulcer. Effects of ranitidine and sucralfate. Eur J Pharmacol 205:101-103.
25. Namiot Z, Rutkiewicz J, Stasiewicz J, and Gorski J (1990) Adenosine deaminase activity in the human gastric mucosa in relation to acid secretion. Digestion 45:172-175.
26. Nie Z, Mei Y, Malek RL, Marcuzzi A, Lee NH, and Ramkumar V (1999) A role of p75 in NGF-mediated down-regulation of the A(2A) adenosine receptors in PC12 cells. Mol Pharmacol 56:947-954.
27. Peachey JA, Hourani SM, and Kitchen I (1996) Differential development of adenosine A1 and A2b receptors in the rat duodenum. Br J Pharmacol 119:949-958.
28. Poucher SM, Keddie JR, Singh P, Stoggall SM, Caulkett PW, Jones G, and Coll MG (1995) The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
29. Puurunen J, Ruoff HJ, and Schwabe U (1987) Lack of direct effect of adenosine on the parietal cell function in the rat. Pharmacol Toxicol 60:315-317.
30. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
31. Saffouri B, Weir GC, Bitar KN, and Makhlouf GM (1980) Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol 238:G495-G501.
32. Scarpignato C, Tramacere R, Zappia L, and Del Soldato P (1987) Inhibition of gastric acid secretion by adenosine receptor stimulation in the rat. Pharmacology 34:264-268.
33. Schepp W, Soll AH, and Walsh JH (1990) Dual modulation by adenosine of gastrin release from canine G-cells in primary culture. Am J Physiol 259:G556-G563.
34. Sebastiao AM and Ribeiro JA (1996) Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol 48:167-189.
35. Tabrizchi R and Bedi S (2001) Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther 91:133-147.
36. van Galen PJ, van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, AP IJ, Stiles GL, and Jacobson KA (1994) A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45:1101-1111.
37. Westerberg VS and Geiger JD (1987) Central effects of adenosine analogs on stress-induced gastric ulcer formation. Life Sci 41:2201-2205.
38. Westerberg VS and Geiger JD (1989) Adenosine analogs inhibit gastric acid secretion. Eur J Pharmacol 160:275-281.
39. Yip L, Kwok YN, and Buchan AM (2003) Cellular localization and distribution of neurokinin-1 receptors in the rat stomach. Auton Neurosci 104:95-108.